← Leaderboards
Steve Goodison
State University Of New York At Buffalo
$11,872,929
Attributed
$14,444,273
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,444,273 · 7
By mechanism
R01$12,438,929 · 6
R44$2,005,344 · 1
Top collaborators
- Yijun Sun11 shared
Most similar at State University Of New York At Buffalo
Same institution · by research overlap
- Yijun Sun$3,544,622
- John C Panepinto$7,710,663
Others in their field
Top investigators on “Sampling”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$522,319,685
- David R. Weir · University Of Michigan At Ann Arbor$421,002,438
- David Heimbrook · Leidos Biomedical Research, Inc.$410,224,927
- Eric S Lander · Whitehead Institute For Biomedical Res$395,613,296
- Richard A Gibbs · Baylor College Of Medicine$356,778,395
Research focus
SamplingTumorMalignant NeoplasmsMolecularBaseMolecular ProfilingDiagnosticRecurrenceLifeTumor BiologySeriesInsightClinical ManagementMalignant Neoplasm Of Urinary BladderValidationTechnologyEvaluationInvestigationClinicGenesHealthcare SystemsCystoscopyBladder NeoplasmCancer Detection
Grant awards (35)
Prognostic analysis and progression modeling of basal-like breast cancer using multi-region sequencing$622,328
R01 · FY2025 · CA
Disease Progression Modeling of Bladder Cancer$497,514
R01 · FY2025 · CA · contact PI
Prognostic analysis and progression modeling of basal-like breast cancer using multi-region sequencing$595,029
R01 · FY2024 · CA
Advanced Computational Approaches to Delineating Dynamic Cancer Progression Processes by Using Massive Static Sample Data$338,650
R01 · FY2024 · CA
Prognostic analysis and progression modeling of basal-like breast cancer using multi-region sequencing$668,114
R01 · FY2023 · CA
Disease Progression Modeling of Bladder Cancer$485,702
R01 · FY2023 · CA · contact PI
Advanced Computational Approaches to Delineating Dynamic Cancer Progression Processes by Using Massive Static Sample Data$349,482
R01 · FY2023 · CA
Disease Progression Modeling of Bladder Cancer$507,497
R01 · FY2022 · CA · contact PI
Advanced Computational Approaches to Delineating Dynamic Cancer Progression Processes by Using Massive Static Sample Data$349,612
R01 · FY2022 · CA
Translation of a Clinical Molecular Diagnostic Assay for Bladder Cancer$626,934
R01 · FY2021 · CA · contact PI
Advanced Computational Approaches to Delineating Dynamic Cancer Progression Processes by Using Massive Static Sample Data$356,879
R01 · FY2021 · CA
Translation of a Clinical Molecular Diagnostic Assay for Bladder Cancer$622,819
R01 · FY2020 · CA · contact PI
Advanced Computational Approaches to Delineating Dynamic Cancer Progression Processes by Using Massive Static Sample Data$371,882
R01 · FY2020 · CA
Translation of a Clinical Molecular Diagnostic Assay for Bladder Cancer$585,149
R01 · FY2019 · CA · contact PI
Towards a non-invasive molecular test for bladder cancer$362,478
R01 · FY2019 · CA · contact PI
Translation of a Clinical Molecular Diagnostic Assay for Bladder Cancer$620,469
R01 · FY2018 · CA · contact PI
Towards a non-invasive molecular test for bladder cancer$373,690
R01 · FY2018 · CA · contact PI
Translation of a Clinical Molecular Diagnostic Assay for Bladder Cancer$618,256
R01 · FY2017 · CA · contact PI
Towards a non-invasive molecular test for bladder cancer$373,690
R01 · FY2017 · CA · contact PI
Towards a non-invasive molecular test for bladder cancer$373,691
R01 · FY2016 · CA · contact PI
Development of molecular assays for non-invasive bladder cancer detection$887,068
R44 · FY2015 · CA · contact PI
Towards a non-invasive molecular test for bladder cancer$373,690
R01 · FY2015 · CA · contact PI
Development of molecular assays for non-invasive bladder cancer detection$901,566
R44 · FY2014 · CA · contact PI
Development of molecular assays for non-invasive bladder cancer detection$216,710
R44 · FY2013 · CA · contact PI
Towards a non-invasive molecular test for bladder cancer$253,590
R01 · FY2010 · CA · contact PI
Towards a non-invasive molecular test for bladder cancer$264,521
R01 · FY2009 · CA · contact PI
Towards a non-invasive molecular test for bladder cancer$3,181
R01 · FY2009 · CA · contact PI
Towards a non-invasive molecular test for bladder cancer$267,702
R01 · FY2008 · CA · contact PI
Functional Analysis of metastasis-Associated Proteins$153,049
R01 · FY2008 · CA · contact PI
Functional Analysis of metastasis-Associated Proteins$97,222
R01 · FY2008 · CA · contact PI
Towards a non-invasive molecular test for bladder cancer$279,327
R01 · FY2007 · CA · contact PI
Functional Analysis of metastasis-Associated Proteins$250,948
R01 · FY2007 · CA · contact PI
Functional Analysis of metastasis-Associated Proteins$259,121
R01 · FY2006 · CA · contact PI
Functional Analysis of metastasis-Associated Proteins$265,829
R01 · FY2005 · CA
Functional Analysis of metastasis-Associated Proteins$270,884
R01 · FY2004 · CA